Commercial Stool Tests: What They Can and Cannot Tell You
What consumer gut microbiome stool tests measure, what studies say about their accuracy and usefulness, and how they differ from stool tests doctors order for specific conditions.
Content last updated . This page has not been medically reviewed.
Evidence labels on this page: established (a test with a clear clinical use), insufficient evidence, no good evidence of benefit and marketing claim. See How We Label Evidence in Specialty Topics.
Two very different kinds of stool test
| Clinical stool tests | Consumer microbiome profiling | |
|---|---|---|
| Question asked | Is a specific infection, bleeding or inflammation marker present? | Which microbes are in my gut and is it "healthy"? |
| Example | A stool antigen test for Helicobacter pylori, one of the preferred tests in a 2025 global consensus on stomach cancer prevention [2] | A report listing bacterial groups and a score |
| Evidence label | established for the named use [2] | insufficient evidence for personal health decisions [1] |
Doctors also use blood and stool markers routinely for several digestive disorders, for screening or for monitoring treatment. A 2025 review lists gut microbial markers only among possible future tests. [3]
What studies found about consumer tests
Results differ between companies. In a 2026 study, seven direct-to-consumer services were tested with the same standardized human fecal material from the US National Institute of Standards and Technology. The authors reported major discrepancies within and across providers, with differences between providers as large as the biological differences between donors. [4]Reports can over-promise. In a 2024 European study, one stool sample was sent to six companies. A panel of 21 experts from 8 countries found over-promising messages, a lack of transparency about methods and a lack of reliability in the results. They judged the reports' interpretations and recommendations premature and the analyses of limited clinical use. [5]
One sample is a snapshot. Medication, stool consistency and other personal factors shape the microbiome. In a population study of over 2,200 people, stool consistency had the largest effect size and medication explained the most variance. [6] Laboratory handling also matters: across 15 laboratories, variation depended most on the sample type and origin, then DNA extraction, handling and analysis. [7]
Stool may not mirror the gut lining. A human study found mucosal-associated microbes only partly correlated with the stool microbiome. [8] A separate study reported that some effects of probiotics and antibiotics on gut resistance genes were not reflected in stool samples. [9]
A report is not a diagnosis. In a commercial-test dataset from Japan, no significant differences in gut microbiome composition were found among groups based on depression screening scores, though a few bacterial families were flagged as candidates. The authors noted limits, including no clear medical information on diagnoses. [10] Label: insufficient evidence for using a stool profile to infer mood or mental health. See Microbiome Research and Mental Health.
What a good test report would need
Before acting on any report, ask whether the company can show:- How "healthy" or "normal" was defined, and in whom. See Why There Is No Single Universal "Healthy Microbiome".
- Whether the lab method has been checked against a reference sample.
- Whether people who acted on the advice had better health outcomes than people who did not. Proper evidence not found for consumer microbiome reports meeting this test; the studies and regulator page cited here were checked.
Practical overview of other at-home tests is in Biomarker Tracking and At-Home Tests, and tests sold in integrative practice are covered in Tests Sold in Integrative Practice.
Frequently asked questions
Can a stool test tell me if my microbiome is healthy?
Not reliably. Experts say clinical usefulness is scarce, and a standardized-sample study found large differences between providers. [1][4]
Are commercial stool tests approved by the FDA?
Some direct-to-consumer tests are reviewed and others are not. Tests for general wellness or low-risk purposes are generally not reviewed before sale. [11] Whether a particular product was reviewed is not verified here.
Why would two companies give different results from the same sample?
Methods differ. A 2024 study that sent one sample to six companies found a lack of transparency in methods and a lack of reliability. [5]
Is a stool test ever useful?
Yes, for specific questions. A stool antigen test is one of the preferred ways to detect H. pylori, according to a 2025 global consensus. [2]
Can a microbiome test pick the right probiotic for me?
Proper evidence not found. See Personalized Probiotic Claims.
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
Regulation, in the US and Europe
In Europe, the 2024 expert panel described grey areas in the regulatory status of these kits. It suggested separating kits sold for consumer curiosity, with no mention of disease, from CE-marked in vitro diagnostic kits intended for trained health professionals. [5]
Safety note
References
- Porcari S et al. International consensus statement on microbiome testing in clinical practice. Lancet Gastroenterol Hepatol 2025. PubMed 39647502. Read 2026-10-22.
- Liou JM et al. Screening and eradication of Helicobacter pylori for gastric cancer prevention: Taipei Global Consensus II. Gut 2025. PubMed 40912906. Read 2026-10-22.
- Agbor TA, Khan WI. Recent trend of laboratory tests in common gastrointestinal tract disorders. Diagnostics 2025. PubMed 41374379. Read 2026-10-22.
- Servetas SL et al. Evaluating the analytical performance of direct-to-consumer gut microbiome testing services. Commun Biol 2026. PubMed 41748906. Read 2026-10-22.
- Rodriguez J et al. Microbiome testing in Europe: navigating analytical, ethical and regulatory challenges. Microbiome 2024. PubMed 39695869. Read 2026-10-22.
- Falony G et al. Population-level analysis of gut microbiome variation. Science 2016. PubMed 27126039. Read 2026-10-22.
- Sinha R et al. Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium. Nat Biotechnol 2017. PubMed 28967885. Read 2026-10-22.
- Zmora N et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell 2018. PubMed 30193112. Read 2026-10-22.
- Montassier E et al. Probiotics impact the antibiotic resistance gene reservoir along the human GI tract in a person-specific and antibiotic-dependent manner. Nat Microbiol 2021. PubMed 34226711. Read 2026-10-22.
- Masamura Y et al. Differences in the human gut microbiota with varying depressive symptom severity scores. Biosci Microbiota Food Health 2024. PubMed 39364125. Read 2026-10-22.
- US FDA, Direct-to-Consumer Tests. Read 2026-10-22.